PIRS: Nilai perusahaan marang bathi resik Pieris

Lambang korporat lan logo Pieris Pharmaceuticals Inc (PIRS)

Pieris Pharmaceuticals (PIRS) generates revenue through partnerships to develop biological drugs for combating cancer and respiratory diseases. Management is currently forced to cut secondary projects to preserve capital and regain market confidence. Despite this, the brand is valued for its expertise in developing anti-kallikreins. This price chart featuring the -32.30 indicator clearly illustrates the current position of this player.

PIRS Pieris Pharma: Koefisien rega marang bathi ing interval 04.07.2022 - 13.11.2026

Rincian metrik komprehensif lan analitis Pieris (PIRS)

- rega lan prakiraan konsensus rega:
Rega saham pieris.com|PIRS - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Pieris Pharmaceuticals, Inc.|PIRS - Nilai Total Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Aset Bersih saben Saham Pieris Pharmaceuticals|PIRS - Aset Bersih Perusahaan|Multiplikator Kapitalisasi Pasar marang Nilai Buku pieris.com|PIRS - Total Aset Perusahaan
- data liabilitas lan likuiditas perusahaan:
Rasio Kabeh Utang marang Dana Pribadi Pieris Pharmaceuticals|PIRS - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Pieris Pharma|PIRS - Utang perusahaan|Rasio utang marang aset resik Pieris Pharmaceuticals, Inc.|PIRS - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Pieris Pharmaceuticals|Koefisien jangkoan perantara pieris.com
- data bathi bisnis lan rasio investasi:
PIRS - Bathi resik|Bathi resik sing dikarepake Pieris Pharmaceuticals|PIRS - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Pieris Pharmaceuticals Inc|PIRS - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Pieris Pharmaceuticals, Inc.|PIRS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Pieris Pharmaceuticals|PIRS - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan pieris.com|PIRS - Wutah bathi saben saham ing taun lumaku|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep Pieris Pharmaceuticals
- rincian pendapatan lan dodolan emiten:
PIRS - Pendapatan lan volume dodolan|Pendapatan mangsa ngarep perusahaan pieris.com|PIRS - Multiplikator P/S|Multiplikator Forward P/S Pieris Pharmaceuticals, Inc.
Analisis komprehensif perusahaan:pieris.com - PIRS
Barang unggulan Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals (PIRS) is operating in crisis management mode following the termination of strategic partnerships. Analyzing the issuer's P/E history reveals the market reaction to liquidity risks and cash flow gaps. The multiple correlates market capitalization with net income, measuring the cost of each unit of earnings. High values signal either inflated expectations or a critical collapse in profits. Investors utilize this indicator to assess the viability of management's new business strategy.

Analisis perusahaan pesaing

Pangali P/E haleon.com|Koefisien rega marang bathi KVUE (Kenvue)|VRNA (Verona Pharma PLC) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Jyong Biotech Corp MENS|Ligand Corp (LGND) - Kapitalisasi marang bathi|AMRX: Koefisien rega marang bathi|perrigo.com - Rasio rega pasar marang bathi resik|ALVO: Pangali P/E|Liquidia Corp - Nilai perusahaan marang bathi resik|GLPG (Galapagos Genomics) - Pangali P/E|Kapitalisasi marang bathi ANI Pharmaceuticals Corp ANIP|Rasio rega marang bathi MannKind Corporation (MNKD)|AMPH (amphastar.com) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Pacira BioSciences, Inc. PCRX|SPRY (ARS Pharmaceuticals Inc) - Kapitalisasi marang bathi resik|Theravance - Pangali P/E|Periode bali modal bisnis Aquestive Corp AQST|SCPH: Pangali P/E|Kapitalisasi marang bathi Tectonic Therapeutic (TECX)|Rasio rega marang bathi Tonix Pharmaceuticals Holding Corp.|SXTC: Nilai perusahaan marang bathi resik|Pangali P/E EPRX|Periode bali modal bisnis BioHarvest Sciences Inc|Rasio rega marang bathi eXoZymes Inc EXOZ|Periode bali modal bisnis Oramed (ORMP)|ENTX: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma Inc (ABVC) - Rasio rega marang bathi|Kapitalisasi marang bathi resik CPIX (Cumberland Corp)|QNTM (Quantum BioPharma Ltd) - Pangali P/E|FGEN: Nilai perusahaan marang bathi resik|Pangali P/E TELO|Pangali P/E ranitherapeutics.com (RANI)|Rasio rega marang bathi Synergy CHC SNYR|Nilai perusahaan marang bathi resik RLYB|LEXX - Rasio rega marang bathi|pulmatrix.com (PULM) - Koefisien rega marang bathi|PTHL: Pangali P/E|Aptorum Group (APM) - Pangali P/E|LYRA (Lyra Therapeutics, Inc) - Pangali P/E|Koefisien rega marang bathi Impact BioMedical, Inc. (IBO)|Pangali P/E TNFA|YCBD - Kapitalisasi marang bathi|PainReform - Koefisien rega marang bathi|Pangali P/E Altamira Therapeutics Ltd CYTO|LIPO: Koefisien rega marang bathi|OptiNose Corp - Rasio rega pasar marang bathi resik|PROC: Pangali P/E|PTPI - Periode bali modal bisnis|QLI (Qilian International Holding) - Pangali P/E|Koefisien rega marang bathi Acelyrin Inc. (SLRN)|Pangali P/E TFFP